Preparation of inactivated vaccines against alphaviruses using Semliki Forest virus-white mouse as a model. I. Inactivation experiments and evaluation of double inactivated subunit vaccines.
D000276:Adjuvants, Immunologic; D000818:Animals; D001102:Arbovirus Infections / Q000517:prevention & control; D001389:Azirines / Q000494:pharmacology; D002642:Chick Embryo; D046508:Culture Techniques; D003840:Deoxycholic Acid / Q000494:pharmacology; D004195:Disease Models, Animal; D005347:Fibroblasts; D005557:Formaldehyde / Q000494:pharmacology; D006571:Heterocyclic Compounds; D006898:Hydroxylamines / Q000494:pharmacology; D007120:Immunochemistry; D007783:Lactones / Q000494:pharmacology; D008722:Methods; D051379:Mice; D011422:Propionates; D012503:Saponins / Q000494:pharmacology; D012672:Semliki forest virus / Q000187:drug effects / Q000254:growth & development / Q000276:immunology*; D013501:Surface-Active Agents / Q000494:pharmacology; D014611:Vaccination; D010948:Viral Plaque Assay; D014765:Viral Vaccines
D000276:Adjuvants, Immunologic; D001389:Azirines; D006571:Heterocyclic Compounds; D006898:Hydroxylamines; D007783:Lactones; D011422:Propionates; D012503:Saponins; D013501:Surface-Active Agents; D014765:Viral Vaccines; D003840:Deoxycholic Acid; D005557:Formaldehyde